Meeting
2013 ASCO Annual Meeting
Association of aspirin use with improved 5-year survival in colorectal cancer patients with PIK3CA mutation.
Authors
Nishi Kothari
H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
Nishi Kothari , Timothy Joseph Yeatman , Kate Fisher , Michael J. Schell , Richard D. Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 3644)
DOI
10.1200/jco.2013.31.15_suppl.3644
Abstract #
3644
Poster Bd #
14F
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Aspirin use and survival outcomes in patients (pts) with PIK3CA mutant colorectal cancer (CRC).
First Author: Ben Tran
Poster
2023 ASCO Annual Meeting
The intersection of neighborhood-level disadvantage and overall lung cancer survival.
First Author: Kathleen Kennedy
Poster
2022 ASCO Annual Meeting
Functional impact of somatic mutations in early-onset (EO) versus average onset (AO) microsatellite stable (MSS) stage III colorectal cancer (CRC).
First Author: Emily Harrold
Poster
2021 Gastrointestinal Cancers Symposium
Patient characteristics and survival outcomes in gastrointestinal cancers harboring RNF43 mutations or RSPO3 fusions: a retrospective analysis.
First Author: Paul Sackstein